Emergent Research Logo
Rising demand for vaccines against coronavirus and other diseases is a key factor driving market revenue growth
— Emergent Research
VANCOUVER, British Columbia, Canada, Sept. 7, 2022 /EINPresswire.com/ — The Global Mammalian Cell Culture Market Report evaluates historical and current data along with an in-depth analysis of market dynamics. The report also sheds light on key market growth drivers and restraints that are expected to impact market growth throughout the forecast period. This report highlights potential growth opportunities and limitations that may be faced by prominent players in the industry across the forecast timeline.
Additionally, therapeutic recombinant proteins for autoimmune and genetic diseases such as multiple sclerosis and rheumatoid arthritis are produced using mammalian cell lines. The human IgG antibody MOR103mAb, which targets disease-causing colony-stimulating factors, is currently in clinical trials. Mammalian cell lines have been used to create MAbs that combat cancer, asthma, tuberculosis, and other autoimmune diseases such as psoriatic arthritis and ankylosing spondylitis. This is expected to accelerate market revenue growth between 2022 and 2030.
Get a sample report @ https://www.emergenresearch.com/request-sample/1042
Concerns about contamination of mammalian cell lines with biological contaminants such as bacteria, yeast, mycoplasma, viruses and chemicals such as endotoxins are key factors expected to hamper market revenue growth to some extent. Mammalian cell cultures are shear sensitive and cannot withstand mechanical agitation as they can for bacterial cell lines. This limits opportunities for scale-up of bioprocessing of mammalian cell-based products. In addition, high costs and stringent regulations are other factors expected to restrain market revenue growth.
The report further explores the key players operating in the industry along with their company profiles, product portfolios, expansion strategies, and strategic alliances such as mergers & acquisitions, collaborations, and joint ventures. It also provides insights into its market scope and global standing along with highlights on its performance and financial situation.
Major companies operating in the Mammalian Cell Culture market are:
Merck KGaA, ThermoFisher Scientific Inc., Cytiva, Novartis AG, FUJIFILM Irvine Scientific, Agilent Technologies, Inc., Lonza Group AG, GE Healthcare, PromoCell GmbH, Horizon Discovery Ltd.
Based on product type, the mammalian cell culture market is segmented into:
Emergen Research has segmented the global mammalian cell culture market based on medium, cell line, application, end use, and region.
• Media Outlook (Revenue, USD Billion, 2019-2030)
o classic media
o serum-free medium
o other
• Cell Line Outlook (Revenue, USD Billion, 2019-2030)
o town
o WI-38
o C6
o HEK293
o Spatula
o other
• Application Outlook (Revenue, USD Billion, 2019-2030)
vaccination
o monoclonal antibody
o tissue engineering
o recombinant cell therapeutic proteins
o Cytotoxicity test
o other
• End-Use Outlook (Revenue, USD Billion, 2019-2030)
o Biopharmaceutical industry
o Academic and laboratory
o Drug Testing Laboratories
o other
For more information on the report, please visit https://www.emergenresearch.com/industry-report/mammalian-cell-culture-market.
Regional analysis:
The report further examines markets in key regions of the world in terms of production and consumption patterns, imports and exports, demand-supply ratio, revenue generation, market share and size, and presence of prominent players in the region. Under the regional analysis section, the report also covers expansion plans undertaken by companies in the region.
The major regions of the market are:
• North America
oUnited States
Canada
• Europe
UK
o Italy
o germany
o france
o Rest of the EU
• Asia Pacific
o India
○ Japan
○China
○Korea
o Australia
o Other APAC
• latin america
Chile
o brazil
Argentina
o Rest of Latin America
• Middle East and Africa
o Saudi Arabia
United Arab Emirates
South Africa
o Remaining MEAs
Key questions addressed in the report:
• Who are the key players in the mammalian cell culture industry?
• Which region is expected to dominate the market in the next few years?
• What are the main applications for mammalian cell culture?
• Which segment is expected to gain traction in the next few years?
• What are the key strategies adopted by the major players in the market?
Request Report Customization @ https://www.emergenresearch.com/request-for-customization/1042
Thank you for reading our report. Reports can be customized according to client requirements. For more information or questions about customization, please contact us. We will provide the most suitable report for your needs.
about us:
Emergen Research is a market research and consulting firm that provides syndicated research reports, customized research reports and consulting services. Our solutions identify, target and analyze changes in consumer behavior across demographics and industries, with a pure focus on our clients’ objectives to help clients make smarter business decisions. I’m here. We provide market intelligence research that ensures relevant fact-based research across multiple industries including healthcare, touchpoints, chemicals, types and energy. We constantly update our research to ensure our clients are aware of the latest trends present in the market. Emergen Research has a strong base of experienced analysts in a variety of specialties. Our industry experience and ability to develop concrete solutions to any research problem give our clients an edge over their respective competitors.
inquiry:
Eric Lee
Corporate Sales Specialist
Emergent Research | Web: www.emergenresearch.com
Direct Phone: +1 (604) 757-9756
Email: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blog
Latest Report: Aerospace 3D Printing Market, Military Robot Market
Trend Report: Medical Device Security Market, Pectin Market
Eric Lee
emergent research
+91 90210 91709
email here
Visit us on social media:
Facebook
twitter
LinkedIn
Mammalian Cell Culture Market to Reach $5.31 Billion by 2030
.
Comments
Post a Comment